ArticleInternational journal of heart failure2026

SGLT2 Inhibitors in Transthyretin Amyloid Cardiomyopathy: A Promising Signal, but Not Yet the Final Word.

Darae KimPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.